Pfizer
PFE
3,262 hedge funds and large institutions have $224B invested in Pfizer in 2021 Q4 according to their latest regulatory filings, with 589 funds opening new positions, 1,253 increasing their positions, 1,156 reducing their positions, and 86 closing their positions.
585% more first-time investments, than exits
New positions opened: 589 | Existing positions closed: 86
137% more funds holding in top 10
Funds holding in top 10: 105 → 249 (+144)
40% more capital invested
Capital invested by funds: $160B → $224B (+$63.3B)
16% more funds holding
Funds holding: 2,805 → 3,262 (+457)
1.15% more ownership
Funds ownership: 66.4% → 67.56% (+1.2%)
8% more repeat investments, than reductions
Existing positions increased: 1,253 | Existing positions reduced: 1,156
2% more call options, than puts
Call options by funds: $5.2B | Put options by funds: $5.09B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DZ Bank
Frankfurt Am Main,
Germany
|
+$1.13B |
| 2 |
Coatue Management
New York
|
+$511M |
| 3 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
+$381M |
| 4 |
JP Morgan Chase
New York
|
+$314M |
| 5 |
Two Sigma Advisers
New York
|
+$271M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Boston Partners
Boston,
Massachusetts
|
-$433M |
| 2 |
Sanders Capital
West Palm Beach,
Florida
|
-$324M |
| 3 |
Renaissance Technologies
New York
|
-$321M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$229M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$223M |
PFE Hedge Fund Activity: Q4 2021 in Review
3,262 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q4 2021, worth a combined $224B — up 40% from $160B a quarter earlier.
Buyers outnumbered sellers: 589 funds opened new PFE positions and 86 closed out — a net gain of 503 holders — while 1,253 added to existing stakes and 1,156 trimmed.
The largest buyer was DZ Bank, adding an estimated $1.13B. The largest seller was Boston Partners, cutting an estimated $433M.
- 3,262 institutional investors held Pfizer (PFE) as of Q4 2021, up from 2,805 in Q3 2021.
- Funds reported $224B of Pfizer stock for Q4 2021, up 40% quarter-over-quarter.
- 589 funds opened new Pfizer positions in Q4 2021 and 86 closed out, a net change of +503 holders.
- The largest Pfizer buyer in Q4 2021 was DZ Bank, an estimated $1.13B added.
- The largest Pfizer seller in Q4 2021 was Boston Partners, an estimated $433M sold.
Based on aggregated 13F filings for Q4 2021.